IP Library Granted Patent US 7,427,636
Granted Patent B2
US 7,427,636 · App. 10/832,829 · Granted Sep 23, 2008

Inosine monophosphate dehydrogenase inhibitory phosphonate compounds

Assignee: Gilead Sciences, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,427,636
App. No.
10/832,829
Granted
Sep 23, 2008
Kind
B2
Abstract

The invention is related to phosphorus substituted IMPDH inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

Claims (92)

1. A method for inhibiting IMPDH in vitro comprising contacting a sample in need of such treatment with a conjugate or a pharmaceutically acceptable salt or solvate thereof wherein the conjugate is a compound of formula:

[DRUG]−( A 0 ) nn

wherein:

DRUG is a compound of formula 501:

wherein:

nn is 1, 2, or 3;

A 0 is A 1 , A 2 or W 3 with the proviso that the conjugate includes at least one A 1 ;

Y 1 is independently O, S, N(R x ), N(O)(R x ), N(OR x ), N(O)(OR x ), or N(N(R x )(R x ));

Y 2 is independently a bond, O, N(R x ), N(O)(R x ), N(OR x ), N(O)(OR x ), N(N(R x )(R x )),—S(O) M2 —, or —S(O) M2 —S(O) M2 —; and when Y 2 joins two phosphorous atoms Y 2 can also be C(R 2 )(R 2 );

R x is independently H, R 1 , R 2 , W 3 , a protecting group, or the formula:

wherein:

R y is independently H, W 3 , R 2 or a protecting group;

R 1 is independently H or alkyl of 1 to 18 carbon atoms;

R 2 is independently H, R 1 , R 3 or R 4 wherein each R 4 is independently substituted with 0 to 3 R 3 groups or taken together at a carbon atom, two R 2 groups form a ring of 3 to 8 carbons and the ring may be substituted with 0 to 3 R 3 groups;

R 3 is R 3a , R 3b , R 3c or R 3d , provided that when R 3 is bound to a heteroatom, then R 3 is R 3c or R 3d ;

R 3a is F, Cl, Br, I, —CN, N 3 or —NO 2 ;

R 3b is Y 1 ;

R 3c is —R x , —N(R x )(R x ), —SR x , —S(O)R x , —S(O) 2 R x , —S(O)(OR x ), —S(O) 2 (OR x ), —OC(Y 1 )R x , —OC(Y 1 )OR x , —OC(Y 1 )(N(R x )(R x )), —SC(Y 1 )R x , —SC(Y 1 )OR x , —SC(Y 1 )(N(R x )(R x )), —N(R x )C(Y 1 )R x , —N(R x )C(Y 1 )OR x , or —N(R x )C(Y 1 )(N(R x )(R x ));

R 3d is —C(Y 1 )R x , —C(Y 1 )OR x or —C(Y 1 )(N(R x )(R x ));

R 4 is an alkyl of 1 to 18 carbon atoms, alkenyl of 2 to 18 carbon atoms, or alkynyl of 2 to 18 carbon atoms;

R 5 is R 4 wherein each R 4 is substituted with 0 to 3 R 3 groups;

W 3 is W 4 or W 5 ;

W 4 is R 5 , —C(Y 1 )R 5 , —C(Y 1 )W 5 , —SO M2 R 5 , or —SO M2 W 5 ;

W 5 is carbocycle wherein W 5 is independently substituted with 0 to 3 R 2 groups;

W 6 is W 3 independently substituted with 1, 2, or 3 A 3 groups;

M2 is 0, 1 or 2;

M12a is 1,2,3,4,5,6,7,8,9,10,11 or 12;

M12b is 0,1,2,3,4,5,6,7,8,9,10,11 or 12;

M1a, M1c, and M1d are independently 0 or 1; and

M12c is 0,1,2,3,4,5,6,7,8,9,10,11 or 12.

2. A method of treating Hepatitis C in a mammal, comprising administering a conjugate or a pharmaceutically acceptable salt or solvate thereof, to the mammal wherein the conjugate is a compound of formula:

[DRUG]−( A 0 ) nn

wherein:

DRUG is a compound of formula 501:

wherein:

nn is 1, 2, or 3;

A 0 is A 1 , A 2 or W 3 with the proviso that the conjugate includes at least one A 1 ;

Y 1 is independently O, S, N(R x ), N(O)(R x ), N(OR x ), N(O)(OR x ), or N(N(R x )(R x ));

Y 2 is independently a bond, O, N(R x ), N(O)(R x ), N(OR x ), N(O)(OR x ), N(N(R x )(R x )), —S(O) M2 —, or —S(O) M2 —S(O) M2 —; and when Y 2 joins two phosphorous atoms Y 2 can also be C(R 2 )(R 2 );

R x is independently H, R 1 , R 2 , W 3 , a protecting group, or the formula:

wherein:

R y is independently H, W 3 , R 2 or a protecting group;

R 1 is independently H or alkyl of 1 to 18 carbon atoms;

R 2 is independently H, R 1 , R 3 or R 4 wherein each R 4 is independently substituted with 0 to 3 R 3 groups or taken together at a carbon atom, two R 2 groups form a ring of 3 to 8 carbons and the ring may be substituted with 0 to 3 R 3 groups;

R 3 is R 3a , R 3b , R 3c or R 3d , provided that when R 3 is bound to a heteroatom, then R 3 is R 3c or R 3d ;

R 3a is F, Cl, Br, I, —CN, N 3 or —NO 2 ;

R 3b is Y 1 ;

R 3c is —R x , —N(R x )(R x ), —SR x , —S(O)R x , —S(O) 2 R x , —S(O)(OR x ), —S(O) 2 (OR x ), —OC(Y 1 )R x , —OC(Y 1 )OR x , —OC(Y 1 )(N(R x )(R x )), —SC(Y 1 )R x , —SC(Y 1 )OR x ,—SC(Y 1 )(N(R X )(R x )), —N(R x )C(Y 1 )R x , —N(R x )C(Y 1 )OR x , or —N(R x )C(Y 1 )(N(R x )(R x ));

R 3d is —C(Y 1 )R x , —C(Y 1 )OR x or —C(Y 1 )(N(R x )(R x ));

R 4 is an alkyl of 1 to 18 carbon atoms, alkenyl of 2 to 18 carbon atoms, or alkynyl of 2 to 18 carbon atoms;

R 5 is R 4 wherein each R 4 is substituted with 0 to 3 R 3 groups;

W 3 is W 4 or W 5 ;

W 4 is R 5 , —C(Y 1 )R 5 , —C(Y 1 )W 5 , —SO M2 R 5 , or —SO M2 W 5 ;

W 5 is carbocycle wherein W 5 is independently substituted with 0 to 3 R 2 groups;

W 6 is W 3 independently substituted with 1, 2, or 3 A 3 groups;

M2 is 0, 1 or 2;

M12a is 1,2,3,4,5,6,7,8,9,10,11 or 12;

M12b is 0,1,2,3,4,5,6,7,8,9,10,11 or 12;

M1a, M1c, and M1d are independently 0 or 1; and

M12c is 0,1,2,3,4,5,6,7,8,9,10,11 or 12.

3. The method of claim 1 wherein each A 3 is of the formula:

4. The method of claim 1 wherein each A 3 is of the formula:

wherein Y 2b is O or N(R x ).

5. The method of claim 1 wherein each A 3 is of the formula:

6. The method of claim 1 wherein each A 3 is of the formula:

7. The method of claim 1 wherein each A 3 is of the formula:

wherein Y 2b is O or N(R x ).

8. The method of claim 1 wherein each A 3 is of the formula:

wherein the phenyl carbocycle is substituted with 0, 1, 2, or 3 R 2 groups.

9. The method of claim 1 wherein each A 3 is of the formula:

wherein:

Y 1a is O or S;

Y 2b is O or N(R 2 ); and

Y 2c is O, N(R y ) or S.

10. The method of claim 1 wherein A 0 is of the formula:

wherein each R is independently alkyl.

11. The method of claim 2 wherein each A 3 is of the formula:

12. The method of claim 2 wherein each A 3 is of the formula:

wherein Y 2b is O or N(R x ).

13. The method of claim 2 wherein each A 3 is of the formula:

14. The method of claim 2 wherein each A 3 is of the formula:

15. The method of claim 2 wherein each A 3 is of the formula:

wherein Y 2b is O or N(R x ).

16. The method of claim 2 wherein each A 3 is of the formula:

wherein the phenyl carbocycle is substituted with 0, 1, 2, or 3 R 2 groups.

17. The method of claim 2 wherein each A 3 is of the formula:

wherein:

Y 1a is O or S;

Y 2b is O or N(R 2 ); and

Y 2c is O, N(R y ) or S.

18. The method of claim 2 wherein A 0 of the formula:

wherein each R is independently alkyl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2004
From: CANNIZZARO, CARINA; CHEN, JAMES M.; CHEN, XIAOWU; CHO, AESOP; CHONG, LEE S.; FARDIS, MARIA; KIRSCHBERG, THORSTEN; PYUN, HYUNG-JUNG; WATKINS, WILLIAM J.; ZHANG, JENNIFER R.
To: GILEAD SCIENCES, INC.
Reel/Frame 015200/0659 →
Continuity (9)
Provisional Application 6051425800 · Oct 24, 2003
Provisional Application 6051420200 · Oct 24, 2003
Provisional Application 6051394800 · Oct 24, 2003
Provisional Application 6051358800 · Oct 24, 2003
Provisional Application 6049542500 · Aug 15, 2003
Provisional Application 6049539300 · Aug 15, 2003
Provisional Application 6046584400 · Apr 25, 2003
Provisional Application 6046537700 · Apr 25, 2003
Related Publication 20050256078A1 · Nov 17, 2005